Biotech Values

[Shengli]

I have no opinion on Immunogen but this author ( love his photo ) seems to like it.
I know that some Bio techs offer a good opportunity after they plunge.That is why i like MNTA so much here.Each case though is very different.

Why I Bought ImmunoGen After the Plunge

ImmunoGen (IMGN) is a Waltham, Massachusetts based biotechnology company. On Friday August 27th, 2010, their collaborative partner Genetech, a member of the Roche Group, received a Refuse to File (RTF) letter from the US Food and Drug Administration (FDA) for the accelerated approval of the Bilogic License Application (BLA) for trastuzumab-DM1.

IMGN stock plunged from $8.40 the day before to $5.90 premarket. At the end of the day the stock rested at $5.16; see the chart following for the plunge.


Click on link for charts and rest of article

http://seekingalpha.com/article/222755-why-i-bought-immunogen-after-the-plunge